FORM DEF 14A

Company

Moleculin Biotech, Inc.

Filed

January 2, 2026

Period of Report

February 5, 2026

Accession Number

0001437749-26-000078

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →